Branded formulations — mid-size — Business MegaBrands 2026–27

Mid-size branded formulations covers pharmaceutical companies that market prescription medicines under brand names in India, often focused on therapy areas such as cardiology, dermatology, pain management, anti-infectives or anti-malarials, and that export to emerging and regulated markets. These firms field large medical representative teams across cities and towns. They widen patient access to affordable branded medicines beyond the largest metros.

Slot BMB-167 · Pharmaceuticals · 6 brands in contention · Business MegaBrand: to be announced in 2027

Brands in contention

Listed alphabetically. The order does not reflect evaluation.

CompanyMegaBrands 501
Ajanta Pharma
Emcure Pharmaceuticals
Glenmark
Ipca Laboratories
Macleods
Micro Labs

How this category is evaluated

Every brand in this category is assessed on WCRC's 50-parameter brand evaluation model, across five pillars: Brand Positioning & Recall, Trust & Sentiment, Product, Innovation & Delivery, Sustainability, Governance & ESG, and Digital & Financial Soundness. Scores are compared within the category, and the brand with the strongest result is named the Business MegaBrand. Read the methodology

Frequently asked

Which are the top mid-size pharma companies in India?

The brands in contention for mid-size branded pharmaceutical formulations in the Business MegaBrands 2026–27 cohort are Ajanta Pharma, Emcure Pharmaceuticals, Glenmark, Ipca Laboratories, Macleods and Micro Labs. This is a factual list, not a ranking. WCRC will name one Business MegaBrand after its independent 50-parameter evaluation.

Other categories in Pharmaceuticals

All of Pharma, Life Sciences & Medtech · The 2026–27 cohort

Cite this page: WCRC, Business MegaBrands 2026–27, Branded formulations — mid-size (Slot BMB-167), https://www.mostvaluablebrands.com/business-megabrands/2026-27/pharma-life-sciences-and-medtech/branded-formulations-mid-size/, accessed [date].

WCRC network: WCRC International · WCRC Leaders